About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT05938829

Fetal Growth Restriction: Management Using Two Guidelines - Fetal Growth Antenatal Management Evaluation

The purpose of this study is to compare the composite neonatal adverse outcomes (CNAO) among pregnancies complicated by fetal growth restriction (FGR) managed using the Society of Maternal-Fetal Medic...

Lead sponsor: The University of Texas Health Science Center, Houston•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Hector Mendez-Figueroa, MD

CONTACT

713-566-4674 Hector.MendezFigueroa@uth.tmc.edu

Sunbola S Ashimi Ademola

CONTACT

713-500-6410 Sunbola.S.Ashimi@uth.tmc.edu

Sponsors

Lead Sponsor

The University of Texas Health Science Center, Houston

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•FGR diagnosed during sonographic examinations
•estimated fetal weight less than or a fetal abdominal circumference less than the 10th percentile

Exclusion Criteria

•Multiple gestations with FGR

Related studies

RECRUITINGPhase 3

Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction

NCT05651347 · Fetal Growth Retardation, Stillbirth and Fetal Death, and more

Validation of Sensors for Long-term Non-Invasive Fetal Monitoring

NCT06952777 · Fetal Distress With Antenatal Problem, Fetal Growth Retardation

Bioimpedence and Arterial Function Monitoring at Birth and in Infants

NCT04720690 · Arterial Stiffness, Fetal Growth Retardation, and more

Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth Restriction

NCT05038462 · Fetal Growth Retardation, Intrauterine Growth Restriction

Active Not Recruiting

Cardiac Displacement From Third Trimester to Early Childhood

NCT02583763 · IUGR, Fetal Growth Retardation, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 11, 2023Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment1,100

Start dateJul 2023

Last updatedJul 11, 2023

Condition

Fetal Growth Retardation

Locations shown

The University of Texas Health Science Center at Houston

Houston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 11, 2023Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions